Keywords
How to Cite
Abstract
Although measures for the treatment of typhoid and paratyphoid, which are considered important and relevant in medical practice today, have been improved, the main measure to combat the disease is vaccination. This presented article provides an analysis of the importance, importance and relevance of the vaccine specifically in the prevention of typhoid and paratyphoid. And the main purpose of this presented work is to outline the importance of vaccination and a brief analysis of modern approaches to the prevention of typhoid and paratyphoid. To date, a number of research projects are underway to introduce various generations of vaccines into practice. However, no matter how high the activity of the vaccine is, it requires sufficient knowledge of the specifics of indications for use, contraindications to use and side effects. Thus, over the past hundred years, preventive vaccination has significantly reduced the incidence and mortality from infectious diseases worldwide. This process is regulated by the national schedule of routine vaccination in all countries. All children should be able to reach their full potential in health and well-being, and no child should die from preventable causes.
References
Shakya M, Neuzil KM, Pollard AJ. Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries. J Infect Dis. 2021 Dec 20;224(12 Suppl 2):S770-S774. doi: 10.1093/infdis/jiab393.
Sahastrabuddhe S, Saluja T. Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans. Clin Infect Dis. 2019 Feb 15;68(Suppl 1):S22-S26. doi: 10.1093/cid/ciy884.
Syed KA, Saluja T, Cho H, Hsiao A, Shaikh H, Wartel TA, Mogasale V, Lynch J, Kim JH, Excler JL, Sahastrabuddhe S. Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead. Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S141-S150. doi: 10.1093/cid/ciaa504.
Dougan G, Baker S. Salmonella enterica serovar Typhi and the pathogenesis of typhoid fever. Annu Rev Microbiol 2014; 68:317–36.
Meiring JE, Laurens MB, Patel P, Patel P, Misiri T, Simiyu K, Mwakiseghile F, Tracy JK, Masesa C, Liang Y, Henrion M, Rotrosen E, Gmeiner M, Heyderman R, Kotloff K, Gordon MA, Neuzil KM. Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi. Clin Infect Dis. 2019 Mar 7;68(Suppl 2):S50-S58. doi: 10.1093/cid/ciy1103.
Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis. 2014 Feb;14(2):119-29. doi: 10.1016/S1473-3099(13)70241-X.
SAGE Working Group on Typhoid Vaccines and the WHO Secretariat. Background paper to SAGE on typhoid vaccine policy recommendations. Geneva, Switzerland: World Health Organization, 2017.
Намазова-Баранова Л. С., Федосеенко М. В., Баранов А. А. Новые горизонты Национального календаря профилактических прививок. Вопросы современной педиатрии. 2019; 18 (1): 13–30. doi: 10.15690/vsp.v18i1.1988)
Указ Президента РФ № 204 от 7 мая 2018 г. «О национальных целях и стратегических задачах развития Российской Федерации на период до 2024 года». [Presidential Order № 204 «O natsional’nykh tselyakh i strategicheskikh zadachakh razvitiya Rossijskoj Federatsii na period do 2024 goda». (In Russ).] Доступно по: http://www.garant.ru/products/ipo/prime/doc/71837200/. Ссылка активна на 1.10.2018.
Полунина Н.В., Пивоваров Ю.П., Милушкина О.Ю. Про филактическая медицина — основа сохранения здоровья населения // Вестник РГМУ. — 2018. — № 5. — С. 5–13. [Polunina NV, Pivovarov YuP, Milushkina OYu. Profilakticheskaya meditsina — osnova sokhraneniya zdorov’ya naseleniya. Vestnik RGMU. 2018; (5):5–13. (In Russ).] doi: 10.24075/vrgmu.2018.058.
Резолюция Форума экспертов «Российские и международные подходы к вакцинации против пневмококковой инфекции детей и взрослых из групп риска» // Пульмонология. — 2015. — Т. 25. — № 5. — С. 633–637. [Rezolyutsiya Foruma ekspertov «Rossijskie i mezhdunarodnye podkhody k vaktsinatsii protiv pnevmokokkovoj infektsii detej i vzroslykh iz grupp riska». Pul’monologiya. 2015;25(5):633–637. (In Russ).]
Liu Z, Lao J, Zhang Y, Liu Y, Zhang J, Wang H, Jiang B. Association between floods and typhoid fever in Yongzhou, China: effects and vulnerable groups. Environ Res. 2018;167:718–24. https://doi.org/10.1016/j.envres.2018.08.030
Porter CK, Olson S, Hall A, Riddle MS. Travelers’ diarrhea: an update on the incidence, etiology, and risk in military deployments and similar travel populations. Military Med. 2017;182(Suppl2):4–10. https://doi.org/10.7205/MILMED-D-17-00064
Barnett R. Typhoid fever. Lancet. 2016;388(10059):2467. https://doi.org/10.1016/S0140-6736(16)32178-X
Stanaway J, Reiner R, Blacker BF, Goldberg EM, Khalil I, Troeger CE, et al. (GBD 2017 Typhoid and Paratyphoid Collaborators). The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019;19(4):369–81. https:// doi.org/10.1016/S1473-3099(18)30685-6
Wain J, Hendriksen RS, Mikoleit ML, Keddy KH, Ochiai RL. Typhoid fever. Lancet. 2015;385(9973):1136–45. https://doi. org/10.1016/S0140-6736(13)62708-7
Antillón M, Warren JL, Crawford FW, Weinberg DM, Kürüm E., Pak GD, et al. The burden of typhoid fever in lowand middle-income contries: a meta-regression approach. PLoS Negl Trop Dis. 2017;11(2):e0005376. https://doi. org/10.1371/journal.pntd.0005376
Marchello CS, Hong CY, Crump JA. Global typhoid fever incidence: a systematic review and meta-analysis. Clin Infect Dis. 2019;68(Suppl_2):S105–16. https://doi.org/10.1093/cid/ ciy1094
Ратников НН, Акимкин ВГ, Азаров ИИ, Коваленко АН. Актуальность проблемы иммунопрофилактики брюшного тифа на опыте применения вакцины Вианвак в эндемичном по брюшному тифу регионе. Медицинский алфавит. 2016;2(32):24–8. [Ratnikov NN, Akimkin VG, Azarov II, Kovalenko AN. Relevance of typhoid fever immunoprophylaxis on experience of Vianvac vaccine in endemic typhoid region. Meditsinskii alfavit = Medical Alphabet. 2016; 2(32):24–8 (In Russ.)]
Коваленко АН, Ратников НН, Борейко ЛО. Опыт применения брюшнотифозной вакцины Вианвак® в организованном коллективе постоянного пребывания на эндемичной по брюшному тифу территории. Вестник Российской военно-медицинской академии. 2018;(S1):152– 8. [Kovalenko AN, Ratnikov NN, Boreyko LO. Experience of use of typhoid vaccine Vianvac® in organized collective of constant stay in the territory, endemic on a typhoid. Vestnik Rossiiskoi voenno-meditsinskoi akademii = Bulletin of the Russian Military Medical Academy. 2018;(S1):152–8 (In Russ.)]
Коваленко АН, Иванов АМ, Одинаев НС, Рахманов МИ, Мурачев АА. Брюшной тиф: опыт последнего десятилетия. Журнал инфектологии. 2009;1(2/3):69–72. [Kovalenko AN, Ivanov AM, Odynaev NS, Rachmanov MI, Murachev AA. Typhoid fever: the experience of last decade. Zhurnal infektologii = Journal Infectology. 2009;1(2/3):69–72 (In Russ.)] https://doi.org/10.22625/2072-6732-2009-1-2,3- 69-72
Plotkin SL, Plotkin SA. General aspects of vaccination. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 6th ed. Saunders; 2013. https://doi.org/10.1016/C2009-0-49973-2
Hejfec LB, Salmin LV, Lejtman MZ, Kuz’minova ML, Vasil’eva AV, Levina LA, et al. A controlled field trial and laboratory study of five typhoid vaccines in the USSR. Bull World Health Organ. 1966;34(3):321–39.
Лебедев СМ. К 100-летию введения в обязательном порядке профилактических прививок против брюшного тифа в войсках. Военная медицина. 2015;(4):152–4. [Lebedev SM. To 100 anniversary of introduction without fail preventive typhoid vaccinations in troops. Voennaya meditsina = Military Medicine. 2015;(4):152–4 (In Russ.)]
Таточенко В.К. Календарь иммунопрофилактики во втором десятилетии XXI века // Вопросы современной педиатрии. — 2010. — Т. 9. — № 3. — С. 81–87. [Tatochenko VK. Calendar of immunoprophylaxis in second decade XXI century. Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(3):81–87. (In Russ).]
Vaccine schedules in all countries of the European Union. Available from: https://vaccine-schedule.ecdc.europa.eu.
Ишмухаметов А.А., Дьяков И.Н. Национальный календарь профилактических прививок. Современные реалии и перспективы развития // Ремедиум. Журнал о российском рынке лекарств и медицинской техники. — 2014. — № 1–2. — С. 4–5. [Ishmukhametov AA, Dyakov IN. National vaccination schedule. Current reality and future prospects. Remedium. 2014;(1–2):4–5. (In Russ).]
Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger, United States, 2018. Available from: https://www.aap.org/en-us/Documents/ immunization_schedule2018.pdf.
National Immunisation Program Queensland Schedule. 2018 Available from: https://www.health.qld.gov.au/clinical-practice/guidelines-procedures/diseases-infection/immunisation/ schedule.
This work is licensed under a Creative Commons Attribution 4.0 International License.